Gemcitabine and Nab-Paclitaxel Infusion Schedule for Metastatic Pancreatic Cancer
Phase 2
53
about 5.5 years
18+
1 site in OH
What this study is about
This trial is testing a new way to give gemcitabine and nab-paclitaxel, two chemotherapy drugs, to people with pancreatic cancer that has spread. The goal is to see if this schedule improves how well the treatment works.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Gemcitabine
- 2.Take Nab-paclitaxel
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
gemcitabine, paclitaxel (Taxane chemotherapy; stabilizes microtubules)
injection (Injection), infusion
Primary: Overall response rate (ORR)
Secondary: Disease control rate, Incidence of adverse events (AEs), Overall survival (OS), Progression-free survival (PFS)
Oncology